The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
Objective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed b...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2014/901437 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832560453187796992 |
---|---|
author | Jie Li Li Peng Hong Du Yangtian Wang Bin Lu Yixin Xu Xiaozhen Ye Jiaqing Shao |
author_facet | Jie Li Li Peng Hong Du Yangtian Wang Bin Lu Yixin Xu Xiaozhen Ye Jiaqing Shao |
author_sort | Jie Li |
collection | DOAJ |
description | Objective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed by a one-time dose of streptozotocin (STZ) to establish the diabetes mellitus model. After that, rats were randomly divided into two groups with or without BPS intervention. After 8 weeks, we explored the role of the p38 MAPK signaling pathway in inflammation, oxidative stress, cardiac morphology, and myocardial apoptosis. Results. Compared with control, the ratio of heart-weight to body-weight and the serum levels of SOD and GSH in the BPS group significantly increased, the expression of p38 MAPK, the serum levels of MDA, TGF-β1, TNF-α, HIF-1α, MMP-9, caspase-3, BNP, ANP, and heart Bax expression significantly decreased, and heart Bcl-2 expression significantly increased. H&E staining in diabetic rats showed the cardiac muscle fibers derangement, the widening gap, the pyknotic and fragmented nuclei, and more apoptosis. Conclusions. BPS effectively showed protective effects on diabetic myocardial cells, possibly through the inhibition of p38 MAPK signaling pathway. |
format | Article |
id | doaj-art-c90521aa374a4e488071f8b78baa237f |
institution | Kabale University |
issn | 1687-8337 1687-8345 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Endocrinology |
spelling | doaj-art-c90521aa374a4e488071f8b78baa237f2025-02-03T01:27:35ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/901437901437The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD RatsJie Li0Li Peng1Hong Du2Yangtian Wang3Bin Lu4Yixin Xu5Xiaozhen Ye6Jiaqing Shao7Department of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaObjective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed by a one-time dose of streptozotocin (STZ) to establish the diabetes mellitus model. After that, rats were randomly divided into two groups with or without BPS intervention. After 8 weeks, we explored the role of the p38 MAPK signaling pathway in inflammation, oxidative stress, cardiac morphology, and myocardial apoptosis. Results. Compared with control, the ratio of heart-weight to body-weight and the serum levels of SOD and GSH in the BPS group significantly increased, the expression of p38 MAPK, the serum levels of MDA, TGF-β1, TNF-α, HIF-1α, MMP-9, caspase-3, BNP, ANP, and heart Bax expression significantly decreased, and heart Bcl-2 expression significantly increased. H&E staining in diabetic rats showed the cardiac muscle fibers derangement, the widening gap, the pyknotic and fragmented nuclei, and more apoptosis. Conclusions. BPS effectively showed protective effects on diabetic myocardial cells, possibly through the inhibition of p38 MAPK signaling pathway.http://dx.doi.org/10.1155/2014/901437 |
spellingShingle | Jie Li Li Peng Hong Du Yangtian Wang Bin Lu Yixin Xu Xiaozhen Ye Jiaqing Shao The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats International Journal of Endocrinology |
title | The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats |
title_full | The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats |
title_fullStr | The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats |
title_full_unstemmed | The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats |
title_short | The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats |
title_sort | protective effect of beraprost sodium on diabetic cardiomyopathy through the inhibition of the p38 mapk signaling pathway in high fat induced sd rats |
url | http://dx.doi.org/10.1155/2014/901437 |
work_keys_str_mv | AT jieli theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT lipeng theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT hongdu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT yangtianwang theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT binlu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT yixinxu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT xiaozhenye theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT jiaqingshao theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT jieli protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT lipeng protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT hongdu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT yangtianwang protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT binlu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT yixinxu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT xiaozhenye protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats AT jiaqingshao protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats |